| Followers | 48 |
| Posts | 12087 |
| Boards Moderated | 0 |
| Alias Born | 09/12/2017 |
Saturday, February 09, 2019 8:05:17 AM
CelzFans uses the "$CELZ" moniker.
https://twitter.com/celzfans
No mention whatsoever of "$CELZ" anywhere on the official creativemedicaltechnologyholdings.com website.
Postings from the so called CMTH facebook page:
At Creative Medical Technology Holdings Inc $CELZ we use bone marrow stem cells, which are very rich in endothelial progenitor cells, as a therapy for erectile dysfunction patients that do not respond to pharmacological interventions such as Viagra
Some investigators try different types of stem cells for treating erectile dysfunction. At Creative Medical Technology Holdings $CELZ we use the patient's own bone marrow, because bone marrow cells have been shown to be safe in many clinical trials.
Publication from the Principle Investigator of our clinical trial from back in 2004...he was thinking about stem cells for erectile dysfunction...now Creative Medical Technology Holdings $CELZ is performing this !
At Creative Medical Technology Holdings Inc $celz we are running clinical trials using bone marrow stem cells in erectile dysfunction patients that are not responding to Viagra
At Creative Medical Technology Holdings $celz we are developing Caverstem, a procedure that uses the patient's own bone marrow stem cells to improve erectile function by repairing blood vessels and smooth muscle
At Creative Medical Technology Holdings Inc $CELZ we are running a clinical trial using bone marrow stem cells to treat erectile dysfunction in patients for who traditional medicines like Viagra don't work
https://www.facebook.com/CreativeMedicalTechnologyHoldings/?epa=SEARCH_BOX
https://twitter.com/celzfans
the "Fan Boy" fake page
No mention whatsoever of "$CELZ" anywhere on the official creativemedicaltechnologyholdings.com website.
Postings from the so called CMTH facebook page:
At Creative Medical Technology Holdings Inc $CELZ we use bone marrow stem cells, which are very rich in endothelial progenitor cells, as a therapy for erectile dysfunction patients that do not respond to pharmacological interventions such as Viagra
Some investigators try different types of stem cells for treating erectile dysfunction. At Creative Medical Technology Holdings $CELZ we use the patient's own bone marrow, because bone marrow cells have been shown to be safe in many clinical trials.
Publication from the Principle Investigator of our clinical trial from back in 2004...he was thinking about stem cells for erectile dysfunction...now Creative Medical Technology Holdings $CELZ is performing this !
At Creative Medical Technology Holdings Inc $celz we are running clinical trials using bone marrow stem cells in erectile dysfunction patients that are not responding to Viagra
At Creative Medical Technology Holdings $celz we are developing Caverstem, a procedure that uses the patient's own bone marrow stem cells to improve erectile function by repairing blood vessels and smooth muscle
At Creative Medical Technology Holdings Inc $CELZ we are running a clinical trial using bone marrow stem cells to treat erectile dysfunction in patients for who traditional medicines like Viagra don't work
https://www.facebook.com/CreativeMedicalTechnologyHoldings/?epa=SEARCH_BOX
Recent CELZ News
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 04/24/2026 08:45:24 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/20/2026 08:45:28 PM
- Creative Medical Technology Holdings Achieves Second WHO INN Milestone, Strengthening Global Regulatory Positioning Across Expanding Cell Therapy Pipeline • GlobeNewswire Inc. • 02/10/2026 02:00:00 PM
- Creative Medical Technology Holdings Reaches Major Clinical Inflection Point with Positive Interim Data from ADAPT Trial and CELZ-201 (Olastrocel) in the Treatment of Chronic Lower Back Pain • GlobeNewswire Inc. • 01/13/2026 02:15:00 PM
- Creative Medical Technology Holdings Receives Regulatory Approval for BioDefense Burn Pit Initiative • GlobeNewswire Inc. • 01/06/2026 02:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/31/2025 09:05:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/19/2025 09:01:58 PM
- Creative Medical Technology Holdings, Inc. Completes Enrollment in FDA-Cleared ADAPT Trial for CELZ-201-Olastrocel, Marking Major Clinical Inflection Point • GlobeNewswire Inc. • 12/17/2025 02:15:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/16/2025 09:05:24 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/15/2025 05:15:26 AM
- Creative Medical Technology Holdings Announces World Health Organization Approval of “olastrocel” as INN for Lead Allogeneic Cell Therapy CELZ-201 • GlobeNewswire Inc. • 12/02/2025 02:15:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 11/21/2025 09:31:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2025 11:12:58 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/07/2025 09:46:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 08:05:42 PM
- Creative Medical Technology Holdings, Inc. Ignites Next-Gen Regenerative BioDefense Initiative for U.S. Veterans Exposed to Burn Pits • GlobeNewswire Inc. • 10/30/2025 01:15:00 PM
- Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $4.2 Million Gross Proceeds • GlobeNewswire Inc. • 10/29/2025 01:00:00 PM
- Creative Medical Technology Holdings Issues Letter to Shareholders • GlobeNewswire Inc. • 10/27/2025 12:15:00 PM
- Creative Medical Technology Holdings Congratulates 2025 Nobel Laureates for Regulatory T Cell Breakthroughs • GlobeNewswire Inc. • 10/07/2025 01:15:00 PM
- Creative Medical Technology Holdings Secures FDA Fast Track Designation for CELZ-201-DDT - Advancing Breakthrough Therapy for Chronic Lower Back Pain • GlobeNewswire Inc. • 08/13/2025 01:01:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2025 08:45:55 PM
